Does Omega-3 help heart health? (Grade B evidence)
Explore current source-reported research for this exact question. These records are separate from the synthesis below; they do not update its grade or establish a recommendation.
For heart health, Omega-3 carries Grade B evidence: probably helps, moderate certainty; effect size may shrink with better trials. Dose range 1–2 g/day EPA/DHA.
Exact question reviewed
- Population
- not reported
- Intervention
- Omega-3 · 1–2 g/day EPA/DHA
- Comparator
- not reported
- Outcome
- heart health
- Time horizon
- not reported
Bottom line. For heart health, Omega-3 carries Grade B evidence: probably helps, moderate certainty; effect size may shrink with better trials. Dose range 1–2 g/day EPA/DHA. [1 other]
- Direction
- benefit
- Magnitude
- modest cardiovascular benefit; large recent trials were mixed
- Grade
- B
- Certainty
- moderate
- Clinical meaning
- small but potentially useful
- Who it applies to
- —
- Dose / form studied
- 1–2 g/day EPA/DHA
- Safety
- serious_with_warfarin
- The one limitation
- Claim-specific limitation details are not available in this public record.
Reviewed not reported · Evidence last changed · Open evidence record (version 0)
⚠ Safety in context
- seriouswith Warfarin: High-dose omega-3 with warfarin may increase bleeding risk. full interaction →
Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.
Who it works for
The studied population is not reported in this public record. Recorded studied dose: 1–2 g/day EPA/DHA.
Evidence
| Study | Design | Role | Cite |
|---|---|---|---|
| Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals | peer-reviewed | not classified | PMID:29387889 · DOI |
Why this grade
Reasoning trace
The current record stores Grade B at moderate certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.
Audit and version
- Claim ID
- ec_omega3_heart
- Claim version
- not reported
- Governance
- legacy, not verified
- Clinician review
- Not yet reviewed by a licensed clinician
- Last evidence search
- not reported
- Last editorial review
- not verified
Dose & form
Studied intake: 1–2 g/day EPA/DHA.
People say · Evidence shows
“Fish oil prevents heart attacks”
Evidence: Grade B — modest cardiovascular benefit; large recent trials were mixed.
How it stacks up for heart health
- Omega-3 vs CoQ10 for heart health — CoQ10 Grade D
- Omega-3 vs Berberine for heart health — Berberine Grade B
- Omega-3 vs Magnesium for heart health — Magnesium Grade B
- Omega-3 vs Vitamin D for heart health — Vitamin D Grade —
- Omega-3 vs Vitamin C for heart health — Vitamin C Grade C
- Omega-3 vs Creatine for heart health — Creatine Grade —
- All interventions graded for heart health →
Grade history
- B → BCorrection by Claude (gold-standard provenance sweep): live Postgres source drift replaced with the verified seed source set [pmid:29387889] details →
- B → BA large cardiovascular outcomes trial missed its primary endpoint; state softened to mixed. details →
Re-review cadence: every 12 months (Grade A/B) · methodology v1.
Frequently asked
How long does Omega-3 take to work for heart health?
This record does not report a studied onset time for Omega-3 and heart health. Do not assume a typical timeframe.
What dose was used in studies of Omega-3 for heart health?
The recorded studied dose for Omega-3 and heart health is 1–2 g/day EPA/DHA. This is a source detail, not a dose recommendation.
Does Omega-3 work for heart health if I'm not deficient?
The studied population is not reported for Omega-3 and heart health, so whether baseline status changes the effect is not known from this record.
Omega-3 or the next-best alternative for heart health?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- modest cardiovascular benefit; large recent trials were mixed
- Substrate's interpretation
- The current reviewed record assigns Grade B at moderate certainty. A domain-by-domain rationale is shown only when recorded.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Does Omega-3 help heart health? (Grade B). https://evidencebased.info/interventions/omega-3/heart-health. Updated 2026-07-16.
BibTeX
@misc{substrate_onsomega3hearthealth,
author = {Substrate editorial},
title = {Does Omega-3 help heart health?},
year = {2026},
url = {https://evidencebased.info/interventions/omega-3/heart-health},
note = {Grade B, evidencebased.info}
}Found something wrong on this page? Report an error →
Current source-reported research
Membership uses admitted intervention and measured-outcome associations for this exact question. Different populations, preparations, comparators and timepoints remain separate. No pooling or update to the synthesis is asserted.